Patients with MEN1-related pituitary tumors tend to have a less favorable response to these standard treatments, with normalization of pituitary hormone levels observed in only 42% of MEN1 cases, compared to a 90% success rate in patients with sporadic pituitary tumors [7]. Here, MEN1 is linked to pituitary tumor.